Skip to main content
SpringerLink
Log in

Myeloid disease

Another action of a thalidomide derivative

  • News & Views
  • Published:

From Nature

View current issue Submit your manuscript

Lenalidomide effectively treats a blood disorder caused by the 5q chromosomal deletion. A study shows that the drug binds to its target, CRBN, to promote the breakdown of an enzyme encoded by a gene in the 5q region. See Article p.183

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Thalidomide and its derivatives confer the substrate specificity of CRBN.

Notes

  1. See all news & views

References

  1. Ito, T., Ando, H. & Handa, H. Cell. Mol. Life Sci. 68, 1569–1579 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. List, A. et al. N. Engl. J. Med. 355, 1456–1465 (2006).

    Article  CAS  PubMed  Google Scholar 

  3. Krönke, J. et al. Nature 523, 183–188 (2015).

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  4. Ito, T. et al. Science 327, 1345–1350 (2010).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Fischer, E. S. et al. Nature 512, 49–53 (2014).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  6. Chamberlain, P. P. et al. Nature Struct. Mol. Biol. 21, 803–809 (2014).

    Article  CAS  Google Scholar 

  7. Krönke, J. et al. Science 343, 301–305 (2014).

    ADS  PubMed  Google Scholar 

  8. Lu, G. et al. Science 343, 305–309 (2013).

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  9. Gandhi, A. K. et al. Br. J. Haematol. 164, 811–821 (2014)

    Article  CAS  PubMed  Google Scholar 

  10. Järås, M. et al. J. Exp. Med. 211, 605–612 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hartmann, M. D. et al. J. Struct. Biol. 188, 225–232 (2015).

    Article  Google Scholar 

  12. Tan, X. et al. Nature 446, 640–645 (2007).

    Article  ADS  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Takumi Ito and Hiroshi Handa are in the Department of Nanoparticle Translational Research, Tokyo Medical University, Shinjuku-ku, Tokyo, 160-8402, Japan.,

    Takumi Ito & Hiroshi Handa

Authors
  1. Takumi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Handa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Handa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ito, T., Handa, H. Another action of a thalidomide derivative. Nature 523, 167–168 (2015). https://doi.org/10.1038/nature14628

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature14628

  • Springer Nature Limited

This article is cited by

Search

Navigation